Friday, June 27, 2025 6/27/2025

PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1

Award Number: R03HD044783
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/03/2003
PERIOD OF PERFORMANCE END DATE: 08/31/2005

Group Awards By:

View Award Description

PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1 - DESCRIPTION (provided by applicant): Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders in children. The most common and serious consequence of NF1 is the reduction of life expectancy by neoplasms. The underlying hypothesis for this proposal is that, in addition to angiogenesis mediated by tumor-derived factors, the molecular defect associated with neurofibromatosis type 1 may also promote tumor neovascularization by directly activating the proliferation of vascular pericytes. This proposal will establish pericytes and NG2 proteoglycan, which has a functional role in angiogenesis, as novel cellular and molecular targets for the anti-angiogenic treatment of NF1-associated tumors. Specific Aims: 1) To use pericyte-specific markers to delineate in detail the temporal and spatial relationship between pericytes and endothelial cells in the neovasculature of NF1-derived tumors. 2) To determine whether interference with the function of a key pericyte component, the NG2 proteoglycan, inhibits NF1 tumor vascularization and progression. This will be done through both genetic (i.e. the NG2 null mouse) and immunochemical (i.e. NG2 blocking antibody) approaches. 3) To demonstrate increased proliferation of mural cells in the micro and macrovasculature of embryonic NF1-/- mice, to document the developmental consequences of this phenomenon, and to demonstrate the possibility of rescuing these NF1-associated defects via ablation of NG2. Research Design: 1) de novo and orthotopic xenograft NF1 tumor models will be used to study the details of the vascular pericyte/endothelial cell relationship. 2) The anti-angiogenic efficacy of NG2 neutralizing antibody will be evaluated in a mouse corneal model of NF1 tumor neovascularization. In addition, a breeding strategy will be developed with NF1+/- mice and NG2 knockout mice to yield NF1+/-NG2+/+ and NF1+/- NG2-1- mice. Vascularization of orthotopic NF1-derived glioma xenografts will be compared in these two genotypes. In the absence of xenografts, the investigators will also follow these 2 groups of mice for 2 years in order to compare de novo tumor onset and progression. 3) The investigators will examine the effect of the NF1-/- and NF1-/+ genotypes on microvascularization in embryonic development. The ability of NG2 ablation to rescue micro and macrovascular defects will be determined.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2004 ( Subtotal = $97,750 )
2004	2004	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	3	7/26/2004	NON-COMPETING CONTINUATION	$97,750
														Subtotal = $97,750

Issue Date FY: 2003 ( Subtotal = $97,750 )
2003	2003	THE BURNHAM INSTITUTE	10901 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	1	6/11/2003	NEW	$0
2003	2003	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	2	8/29/2003	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$97,750
														Subtotal = $97,750

Grand Total All Awards = $195,500

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1

Award Number: R03HD044783

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/03/2003

PERIOD OF PERFORMANCE END DATE: 08/31/2005

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer